Viewing StudyNCT00414765



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00414765
Status: COMPLETED
Last Update Posted: 2021-06-08
First Post: 2006-12-21

Brief Title: Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Metastatic Melanoma
Metastatic Renal Cell Carcinoma
Keywords:
Name View
IL-2 View
Metastatic Renal Cell Carcinoma View
Metastatic Melanoma View
Aldesleukin View